Loading…
Loading…
Aimei Health Technology Co., Ltd. (NASDAQ: AFJK - Get Free Report)'s share price rose 0.4% during trading on Tuesday. The company traded as high as $12.14 and last traded at $12.01. Approximately 84,299 shares were traded during trading, an increase of 194% from the average session volume of 28,719 shares. The stock had previously closed
Aimei Health Technology Co. , Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the "Company") announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc.
Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto.
New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (the "Company") (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the "Quarterly Report") with the U.
New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Quarterly Report was due on May 15, 2026.
New York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (the "Company") (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Annual Report") with the U.
New York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company's delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Annual Report was due on March 31, 2026, and the Company filed a Notification of Late Filing on Form 12b-25 with the SEC on April 1, 2026.
Aimei Health Technology Co., Ltd. (NASDAQ: AFJK - Get Free Report)'s share price was up 0.4% on Tuesday. The stock traded as high as $36.99 and last traded at $33.49. Approximately 4,450 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 6,708 shares. The stock had previously closed